BMJ 1995;311:55-56 (1 July)

Letters

Study did not consider treatment efficacy

EDITOR,--The papers on suicide and antidepressants in the issue of 28 January develop our understanding of this problem further. John A Henry and colleagues point out the differences in the rate of death by overdose for different antidepressants1 but fail to relate this to efficacy and the fact that only 4-5% of all suicides are due to an overdose of antidepressant.2 Susan S Jick and colleagues show that many people taking antidepressants commit suicide but do not give data on the number of suicides that occur in untreated depressed patients.3 Interestingly, they found a distinct difference in crude rates of suicide between people taking tricyclic antidepressants (7.4 (range 4.7-8.7) suicides/10000 person years) and people taking non-tricyclic antidepressants (flupenthixol, mianserin, fluoxetine, or trazodone; 14.9 (12.0-19.0) suicides/10000 person years). The further analyses of fluoxetine, the antidepressant with the highest crude rate of suicide (19.0/10000 person years), suggested that this rate could partly . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Relative mortality from overdose of antidepressants
John A Henry, Carol A Alexander, and Ersin K Sener
BMJ 1995 310: 221-224. [Abstract] [Full Text]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ